Metaphor-Based Smoking Cessation Intervention

August 31, 2026 updated by: Beijing Normal University

Metaphor-Based Smoking Cessation Intervention: A Randomized Controlled Trial

This study aims to evaluate the effectiveness and participant experiences of a WeChat-delivered, metaphor-based smoking cessation intervention.

Study Overview

Detailed Description

This randomized controlled trial evaluates a WeChat-delivered, metaphor-based smoking cessation intervention. Participants in the intervention group will receive staged cessation messages that use metaphors to explain smoking urges, nicotine dependence, behavior change, coping strategies, and relapse prevention. The intervention will also include self-monitoring, personalized feedback, and a personalized journey map to help participants recognize their progress during the cessation process.

Participants in the control group will receive brief smoking cessation advice. The study will compare the two groups in terms of smoking cessation outcomes. It will also assess participants' perceptions of the intervention, including the usefulness and comprehensibility of the metaphors, willingness to engage with the intervention, immersion in the cessation process, perceived support, and overall satisfaction.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Zhuhai, Guangdong, China, 519087
        • Beijing Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. aged 18 and above, reside in Zhuhai for the next 6 months;
  2. smoke at least 1 cigarette or use e-cigarettes daily;
  3. Having a smartphone and a WeChat account, being able to use WeChat skillfully.

Exclusion Criteria:

  1. Smokers who have communication barrier (either physically or cognitively);
  2. Smokers who are currently participating in other SC programmes or services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
5A's/5R's advice + health warning leaflet
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
The 5A's approach (Ask, Advise, Assess, Assist, and Arrange) will be used for participants who are ready to quit, and the 5R's approach (Relevance, Risks, Rewards, Roadblocks, and Repetition) will be used for participants who are not ready to quit.
Experimental: Metaphor-based intervention group
Metaphor-based smoking cessation intervention + 5A's/5R's advice + health warning leaflet
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
Participants will receive a 100-day, WeChat-delivered smoking cessation intervention using metaphors such as "fog" and "restart" to describe smoking urges, nicotine dependence, and the process of behavior change. The intervention will provide staged messages on smoking-trigger identification, self-monitoring, action planning, coping strategies, environmental modification, social support, and relapse prevention, together with personalized feedback and a personalized journey map to help participants review their cessation experiences and progress.
The 5A's approach (Ask, Advise, Assess, Assist, and Arrange) will be used for participants who are ready to quit, and the 5R's approach (Relevance, Risks, Rewards, Roadblocks, and Repetition) will be used for participants who are not ready to quit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical validated quit rate at 6 months follow-up
Time Frame: 6 months follow-up
The primary outcomes are biochemically validated quit rate (exhaled carbon monoxide < 4 ppm or salivary cotinine < 30 ng/ml)
6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported 7-day point prevalence quit rate
Time Frame: 3 and 6 months follow-up
Self-reported 7-day point prevalence quit rate in the two groups
3 and 6 months follow-up
Smoking reduction rate
Time Frame: 3 and 6 months follow-up
Rate of smoking reduction by at least half of baseline amount in the two groups
3 and 6 months follow-up
Eligibility rate
Time Frame: baseline
the percentage of eligible smokers out of the total number of smokers screened
baseline
Consent rate
Time Frame: baseline
the percentage of eligible smokers who agree to participate out of the total number of eligible smokers
baseline
Biochemical validated quit rate at 3 months follow-up
Time Frame: 3 months follow-up
biochemically validated quit rate (exhaled carbon monoxide < 4 ppm or salivary cotinine < 30 ng/ml)
3 months follow-up
Intervention Engagement
Time Frame: 3 months follow-up
Participants' engagement with the intervention, including self-reported reading of WeChat cessation messages, interaction with the health assistant, and viewing of the personalized journey map.
3 months follow-up
Perceived Usefulness of Metaphors
Time Frame: 3 months follow-up
Participants' perceived usefulness of the metaphors used in the intervention. Responses will be assessed using a 7-point Likert scale.
3 months follow-up
Narrative Engagement in the Smoking Cessation Journey
Time Frame: 3 months follow-up
Participants' engagement with the journey-based intervention, including whether the staged challenge design increased their motivation to persist, whether they were interested in subsequent stages, and whether they felt immersed in the smoking cessation journey. Responses will be assessed using a 7-point Likert scale.
3 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xue Weng, Beijing Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

August 31, 2026

First Submitted That Met QC Criteria

August 31, 2026

First Posted (Actual)

September 3, 2026

Study Record Updates

Last Update Posted (Actual)

September 3, 2026

Last Update Submitted That Met QC Criteria

August 31, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Metaphor Cessation Trial

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe